Rheumatologist - Work-Life Survey Results

Save

During the week of April 3, 2023, registered Rheumatologists responded to an email survey regarding work-life balance. The following are the results from 190 respondents - 53% were male (47% female) and 94% were from the USA.

“You Can Have it All” (4.7.2023)

Save

Dr. Jack Cush reviews the news and highlights from our "Women in Rheumatology" Campaign from last week on RheumNow.com

Antiphospholipid Antibodies With Incident Cardiovascular Events

Save

Are antiphospholipid antibodies (aPL) associated with atherosclerotic cardiovascular (ASCVD) event risk?  A cohort study has shown that aPL Abs are found in a substantial proportion of adults with ASCVD events and finding both positive aCL IgA and aβ2GPI IgA Abs independently predicted futur

Mentoring is Personal

Save

As I was training as a rheumatologist, I found myself drawn to rheumatologic disorders in older patients. In particular, I was intrigued by programmatic development that could improve both disease outcomes and older adults’ quality of life. This was not the “sexiest” topic in rheumatology and it was hard to figure out how to get started. I was extremely fortunate to find a mentor.

Gender Norms in Chronic Pain

Save

Sensitive women and stoical men are the prevalent images of people in chronic pain. Unwarranted differences in medical treatment may result, as a University of Gothenburg doctoral thesis emphasizes.

Disordered Pain Processing in Fibromyalgia

Save

Fibromyalgia is a mysterious chronic pain disorder that is difficult to treat. Its causes are also still largely in the dark.

What Advocacy Taught Me About Leadership

Save

When I first took on the role as the American College of Rheumatology (ACR) Committee on Government Affairs chair, I was keenly aware of being the first woman to be nominated to this position. While the demographics of government officials have changed over the past several decades, governance positions are held overwhelmingly by men. Having my voice heard and advocating for my colleagues at the ACR, and most importantly for our patients, were priorities. 

Steroid-Sparing Rituximab in Polymyalgia Rheumatica

Save

BRIDGE-PMR proof-of-concept trial assessed the efficacy of rituximab (RTX) in patients with polymyalgia rheumatica (PMR) and showed that a single 1000 mg dose of lead to a significant number of glucocorticoid-free remissions after 1 year. 

British Society of Rheumatology Plans Revision of Systemic Sclerosis Guideline

Save

British Society for Rheumatology (BSR) last published its guideline for systemic sclerosis (SSc) in 2016. Given the many advances in the field the BSR has outlined their plans to update the management of SSc.

EMA Final Update on JAK Inhibitors and MACE, Malignancy & VTE Risks

Save

The EMA has updated recommendations regarding the use of JAK inhibitors by issuing a direct healthcare professional communication summarizing the data and warnings regarding an increased risk of malignancy, major adverse cardiovascular events (MACE), serious infections, VTE, and mortality in some patients receiving JAKi for the treatment of chronic inflammatory disorders.

The Origin Story of RheumNow’s Campaign: Women in Rheumatology--The XX Factor

Save

Origin stories have captivated me ever since my childhood spent reading Greek Mythology and Marvel comic books. Superheroes have different powers and personalities.

Intrathecal Methotrexate for Cerebritis (3.31.2023)

Save

Dr. Jack Cush reviews the CV advantage to walking, the OA risk with running and the eczema-OA connection; these articles and journal reports from the past week on RheumNow.com.